Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001209191-23-005993

Chief Executive Officer sold 11,313 shares at $3.91 ($44,234)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Ballal Rahul D. Chief Executive Officer 2023-01-30 Sale −11,313 $3.91 $44,234 120,696 D
Open-market sales · 11,313 sh · avg $3.91 · $44,234
Loading xslF345X03/doc4.xml…